Edoxaban-Based Long-Term Antithrombotic Therapy in Patients with Atrial Fibrillation and Stable Coronary Disease: Rationale and Design of the Randomized EPIC-CAD Trial.
Sign Up to like & getrecommendations! Published in 2022 at "American heart journal"
DOI: 10.1016/j.ahj.2022.01.014
Abstract: BACKGROUND Anticoagulants are the standard therapy for patients with atrial fibrillation (AF) and antiplatelet therapy for those with coronary artery disease (CAD). However, compelling clinical evidence is still lacking regarding the long-term maintenance strategy with… read more here.
Keywords: therapy; trial; long term; term ... See more keywords